• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.38 número2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.38 número2"

Copied!
3
0
0

Texto

(1)

revbrashematolhemoter.2016;38(2):175–177

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Letter

to

the

Editor

Development

of

a

questionnaire

to

assess

knowledge

regarding

blood

donation

in

a

Brazilian

population

DearEditor,

Comprehensivestudiesontheknowledgeandattitudetoward blood donation, considering culturaldifferences and tradi-tions,are useful forplanning strategiesinthe recruitment of non-remunerated blood donors. Several instruments to assessknowledgeregardingblood donationhavebeen pre-sentedinthe scientificliterature1,2 suchasthe instrument

proposedbySabuetal.3 These authorsintroduced a

ques-tionnaireinwhichtheknowledgeofblooddonationamong healthsciencesstudents wasmeasuredusing 12questions basedonthebenefitsofblooddonation,generalrequirements tobecomeaneligibledonorandmedicalconditionsand dis-easesthatrestrictblood donation.Wedevelopeda24-item multiple-choicequestionnaire,takingintoaccountthe speci-ficitiesofthe Brazilian population. Thisquestionnairewas basedonsomeitemsoftheinstrumentdevelopedbyRenzaho andPolonsky4andontheBrazilianlegislationregardingblood

donation. Namedthe “Brazilian blood donation knowledge questionnaire”(BDKQ-Brazil),itcanbecompletedbydonors iftheyareliterateoradministeredviainterview.Itisbelieved thattheBDKQ-Brazilappliestoabroadrangeofpopulation groups.

Thecontent validityofthe proposed questionnairewas evaluatedbycomputingacontentvalidityratio(CVR)5based

on experts’ratings ofitem relevance. Aconvenience sam-pleoftwentyprofessionals (fourmenand sixteenwomen) whowereparticipatingintheMaster’sCoursein Hemother-apyandBiotechnologyoftheUniversidadedeSãoPaulo(USP) in Ribeirão Preto was used for evaluation. All participants were informed ofthe purposeofthe research before sign-inganinformedconsentform.Alltheseexpertscompleted a healthcare undergraduate course and have professional activitiesinhematology servicesorblood donationcenters indifferentBraziliancities(BeloHorizonte,Brasília,Cuiabá, Curitiba,Florianópolis,Ituverava,Manhuac¸u,Recife,Ribeirão PretoandRiodeJaneiro).Themeanageoftheparticipants

was36.1years (range:27–56years)andthe meanlengthof professional experience was 10.7 years (range: 3–30 years). Theexpertswere askedtoclassifyeach itemon the ques-tionnaire as‘essential’, ‘usefulbut not essential’, and ‘not necessary’.Foreachitem,theCVRisgivenby(En/2)/(n/2),

wheren isthe totalnumber ofexpertsand E isthe num-berofexpertsindicating‘essential’.TheCVRrangesbetween

−1and1.Whenlessthanhalfoftheexpertsratedtheitem

as ‘essential’,the valueof CVRwasnegative. Accordingto Wilson et al.,6 whenn=20 and the CVRis greater than or

equalto0.368,thereisevidencethattherespectiveitemis substantiallyusefultorepresentknowledgeregardingblood donation.

(2)

176

revbrashematolhemoter.2016;38(2):175–177

Table1–Itemsoftheproposedinstrumentandtheirrespectivecontentvalidityratios.Theitemsareshowedinthe sameordertheyappearontheinstrument.

No. Item CVR

1 Doyouknowyourbloodtype? −0.7

2 Inordertobeabletodonateblood,whatistheminimumweightthatapersonneedstohave? 0.1

3 Isalldonatedbloodtestedinordertoverifyifithasanydiseasethatcanbetransmittedtoothers? 0.8a

4 Canunder16-yearoldsdonateblood? −0.1

5 Canpregnantwomendonateblood? 0.3

6 Canapersonwhohasdiabetesorhighbloodpressuredonateblood? 0.2

7 Canapersonwhohasorhashadanytypeofcancerdonateblood? 0.2

8 Canwomenwhoaremenstruatingdonateblood? 0.1

9 Isthereamaximumageforblooddonation? 0.1

10 Canwomenwhoarebreastfeedingdonateblood? 0.1

11 Whenapersonneedstoreceiveblood,isthebloodfromonlyonedonorenough? −0.8

12 Whenpeopleneedtoreceiveblood,dotheyhavetopay? −0.3

13 Isittruethatdonatedbloodmustbeusedwithin24hafterthedonation,otherwiseitisnotgood anymore?

−0.4

14 Canapersoncatchadiseasebydonatingblood? 0.7a

15 Isittruethatmaleblooddonorscandonateeverytwomonthsandfemaledonorsevery3months? 0.5a

16 InBrazil,isitallowedbylawtopayapersontodonateblood? 0.1

17 Whensomeonedonatesblood,doestheamountofbloodinthehumanbodyreturntowhatitwas beforewithin24–48h?

0.4a

18 Ifadonorhasafeveronthedayofdonation,canhedonateblood? 0.4a

19 Doesdonatingbloodmakeyouloseorgainweight? −0.5

20 Thecapacityofalittlecoffeecupis50mL.Whenapersondonatesblood,howmuchbloodistaken? −0.3 21 Onceapersonentersinthedonationroomtodonateblood,howlongistheblooddonationprocess? 0.5a

22 Inordertodonateblood,shouldthedonorbefasting? 0.9a

23 Cansmokersdonateblood? 0.1

24 Doesdonatingbloodthickenorthintheblood? −0.3

a Contentvalidityratios(CVRs)greaterthanorequalto0.368.

behaviors.Thesesuggestionsmaybeincludedinfuture ver-sionsofthequestionnaire.

Inafuturestudy,wewillusetheproposedquestionnaireto evaluatetheassociationbetweenseveralvariablesofinterest andtheknowledge,attitudesand practicesregardingblood donationamongusersofprimaryhealthcareservices(study supported bythe Brazilianagency Fundac¸ão de Amparo à Pesquisado Estadode São Paulo– FAPESP –process num-ber14/14020-6).Webelievethattheproposedquestionnaire isasimple,easy-to-useandhelpfulinstrumenttomeasure knowledgeaboutblood donation.However,the assessment ofother aspects, such as validity and reliability, is impor-tant infuture studies,considering differentpopulations of Brazilian-Portuguesespeakers.ItemswithsmallCVRsdonot necessarilyneedtoberemovedfromthequestionnaire,but theymustbereviewedand,ifappropriate,improved.In addi-tion,theclassificationofthescoresand theirpracticaluse shouldbeaddressedinafuturestudyinvolvingalargestudy sample.

Funding

TheConselhoNacionaldeDesenvolvimentoCientíficoe Tec-nológico(CNPq)andtheFundac¸ãodeAmparoàPesquisado EstadodeSãoPaulo(FAPESP).

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.BenNatanM,GorkovL.Investigatingthefactorsaffecting blooddonationamongIsraelis.IntEmergNurs.

2011;19(1):37–43.

2.LemmensKP,AbrahamC,RuiterRA,VeldhuizenIJ,DehingCJ, BosAE,etal.Modellingantecedentsofblooddonation motivationamongnon-donorsofvaryingageandeducation. BrJPsychol.2009;100(1):71–90.

3.SabuKM,RemyaA,BinuVS,VivekR.Knowledgeattitudeand practiceonblooddonationamonghealthsciencestudentsina universitycampus,SouthIndia.OnlineJHealthAlliedScs. 2011;10(2):6.

4.RenzahoAM,PolonskyMJ.Examiningdemographicand socio-economiccorrelatesofaccurateknowledgeaboutblood donationamongAfricanmigrantsinAustralia.TransfusMed. 2012;22(5):321–31.

5.LawsheCH.Aquantitativeapproachtocontentvalidity.Pers Psychol.1975;28(4):563–75.

(3)

revbrashematolhemoter.2016;38(2):175–177

177

MirianeLucindoZucoloto, EdsonZangiacomiMartinez∗

UniversidadedeSãoPaulo(USP),RibeirãoPreto,SP,Brazil

Correspondingauthor at: Departamento de MedicinaSocial,

FaculdadedeMedicinadeRibeirãoPreto,UniversidadedeSão Paulo(USP),Av.Bandeirantesn◦3900,MonteAlegre,14049-900

RibeirãoPreto,SP,Brazil.

E-mailaddress:edson@fmrp.usp.br(E.ZangiacomiMartinez).

Received31October2015 Accepted9February2016 Availableonline9March2016

http://dx.doi.org/10.1016/j.bjhh.2016.02.004

Imagem

Table 1 – Items of the proposed instrument and their respective content validity ratios

Referências

Documentos relacionados

Method: Bone marrow samples from patients with multiple myeloma were used to stan- dardize a panel of five probes [1q amplification, 13q14 deletion, 17p deletion, t(4;14), and

CLL/SLL: chronic lymphocytic leukemia/small lymphocytic lymphoma; DLBCL: diffuse large B-cell lymphoma; BCL-U: B-cell lymphoma, unclassifiable, with features intermediate between

As there is no curative therapy, researchers have been investigating new drugs to treat myeloproliferative neoplasms, including l -amino acid oxidase from Calloselasma rhodostoma

Moreover, the addition of betaine or sodium-4-phenylbutyrate increased the secretion rate of FVIII B proteins in HEK 293 cells, but the same effect was not seen for FVIII

This study describes the prevalence of anemia, hypertension and diabetes and the overall health status in pre-elderly and elderly subjects enrolled in two primary health care

Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment. Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts

Figure 1 – (A) Coronal T1-weighted magnetic resonance imaging after gadolinium administration showing right temporal leptomeningeal, parenchymal (arrow) and pachymeningeal

Need to clarify the cause of hemolysis in case report of newborn with clinically significant hemolytic disease and passive transfer of anti-D from